Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities


Acambis, the vaccine manufacturer, is to be acquired by Sanofi-Aventis of France for £276m.

Acambis is to raise £40m in a share placing to fund the expansion of its vaccine manufacturing and research business, which includes sites in Cambridge and the US.

Acambis has sold Berna Products, the US-based distributor of oral typhoid vaccines with 15 staff, to Crucell for £9m.

Acambis has acquired a US-based 58,000 sq ft vaccine manufacturing facility in Rockville, MD, from BioReliance Corporation for £4m.

Acambis has secured a £28m capital injection from Baxter Healthcare to fund the refurbishment of a US plant to produce the smallpox vaccine.